1. Home
  2. NXJ vs CGEM Comparison

NXJ vs CGEM Comparison

Compare NXJ & CGEM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NXJ
  • CGEM
  • Stock Information
  • Founded
  • NXJ 1999
  • CGEM 2016
  • Country
  • NXJ United States
  • CGEM United States
  • Employees
  • NXJ N/A
  • CGEM N/A
  • Industry
  • NXJ Finance/Investors Services
  • CGEM Biotechnology: Pharmaceutical Preparations
  • Sector
  • NXJ Finance
  • CGEM Health Care
  • Exchange
  • NXJ Nasdaq
  • CGEM Nasdaq
  • Market Cap
  • NXJ 492.3M
  • CGEM 506.1M
  • IPO Year
  • NXJ N/A
  • CGEM 2021
  • Fundamental
  • Price
  • NXJ $11.70
  • CGEM $8.02
  • Analyst Decision
  • NXJ
  • CGEM Strong Buy
  • Analyst Count
  • NXJ 0
  • CGEM 8
  • Target Price
  • NXJ N/A
  • CGEM $32.86
  • AVG Volume (30 Days)
  • NXJ 74.9K
  • CGEM 416.8K
  • Earning Date
  • NXJ 01-01-0001
  • CGEM 05-14-2025
  • Dividend Yield
  • NXJ 3.27%
  • CGEM N/A
  • EPS Growth
  • NXJ N/A
  • CGEM N/A
  • EPS
  • NXJ N/A
  • CGEM N/A
  • Revenue
  • NXJ N/A
  • CGEM N/A
  • Revenue This Year
  • NXJ N/A
  • CGEM N/A
  • Revenue Next Year
  • NXJ N/A
  • CGEM $278.37
  • P/E Ratio
  • NXJ N/A
  • CGEM N/A
  • Revenue Growth
  • NXJ N/A
  • CGEM N/A
  • 52 Week Low
  • NXJ $10.06
  • CGEM $7.90
  • 52 Week High
  • NXJ $12.24
  • CGEM $30.19
  • Technical
  • Relative Strength Index (RSI)
  • NXJ 28.35
  • CGEM 36.91
  • Support Level
  • NXJ $11.66
  • CGEM $8.01
  • Resistance Level
  • NXJ $11.96
  • CGEM $9.16
  • Average True Range (ATR)
  • NXJ 0.10
  • CGEM 0.48
  • MACD
  • NXJ -0.02
  • CGEM -0.00
  • Stochastic Oscillator
  • NXJ 10.00
  • CGEM 4.90

About NXJ Nuveen New Jersey Qualified Municipal Fund

Nuveen New Jersey Quality Municipal Income Fund is a closed-end investment management company. Its objective is to provide current income exempt from regular federal and New Jersey income tax and to enhance portfolio value relative to the municipal bond market by investing in tax-exempt municipal bonds that the Fund's investment adviser believes are underrated or undervalued or that represent municipal market sectors that are undervalued. The company invests a majority of its managed assets in securities rated, at the time of investment, investment grade or, if the bonds are unrated, are judged by the manager to be of comparable quality.

About CGEM Cullinan Oncology Inc.

Cullinan Therapeutics Inc is a biopharmaceutical company. It has a diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, creates differentiated ideas, identifies the appropriate targets, and selects the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications. It has one reporting and one operating segment, which is the business of developing immunology and oncology therapies.

Share on Social Networks: